Newsletter No. 105 -- August 2008NIH
QUANTITATIVE IMAGING FOR EVALUATION OF RESPONSES TO CANCER THERAPIES (U01) (NCI) (PAR-08-225)
Application Due Dates: Standard dates apply
This funding opportunity announcement (FOA) from the Cancer Imaging Program is designed to promote research on quantitative imaging of tumor response to cancer therapies in clinical trial settings, with the overall goal of facilitating clinical decision making. Proposed projects should include the appropriate development and adaptation/implementation of quantitative imaging methods, protocols and software solutions/tools (using existing commercial imaging platforms and instrumentation), and their application in current and planned Phase 1-2 clinical therapy trials. No support for the clinical trials, as such, will be provided under this FOA. The proposed projects must focus on imaging-derived quantitative measurements of responses to drugs and/or radiation therapy, and/or image-guided interventions. It is anticipated that these research goals will require multidisciplinary efforts. Therefore, this FOA solicits applications from multi-disciplinary teams to include oncologists as well as clinical and basic imaging scientists. The involvement of industrial partners in the development of the quantitative imaging methods is not required, but is strongly encouraged. Awardees will form a Quantitative Imaging Network (QIN) to share ideas and approaches to validate and standardize imaging data and related imaging metadata for quantitative measurements of responses to cancer therapies.
PILOT STUDIES IN PANCREATIC CANCER (R21) (NCI) (PA-08-208) (R03) (PA-08-209)
Application Receipt Date(s): Standard dates apply.
This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), solicits the submission of Research Project Grant (R21 or R03) applications from institutions and organizations that propose to promote innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, and treatment of pancreatic cancer. Conduct of ancillary imaging studies in pancreatic clinical trials is included in the specific topics of interest.
URL: (R21) http://grants.nih.gov/grants/guide/pa-files/PA-08-208.html
USING SYSTEMS SCIENCE METHODOLOGIES TO PROTECT AND IMPROVE POPULATION HEALTH (R21)(MULTIPLE INSTITUTES) (PA-08-224)
Application Receipt Date(s): Standard dates apply.
This FOA solicits Exploratory/Developmental (R21) applications from institutions/organizations that propose to apply one or more specific system science methodologies (identified in Section I.1 - "Background", of this announcement) to public health and health care systems problems and contribute knowledge that will enhance effective decision making around the development of and prioritization of policies, interventions, and programs to improve population health, especially where resources are limited and only a limited number of programs/policies/interventions can be implemented. Projects that address policy resistant health problems as they relate to the societal impact of medical innovations such as implantable cardioverter defibrillator's (ICD), or newer diagnostic imaging techniques, …
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCIrequests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof-of-principle clinical trials. See the web site for details.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
Reminders Regarding Inclusion of Special Features in Grant Applications (NOT-OD-08-095)
Applicants should use text only for the following two application components: Description: Project Summary and Relevance, in the PHS 398 paper application (see PHS 398 instructions in Part I, 4.2.1), and Project Summary/Abstract and Project Narrative, in the SF424(R&R) for electronic submissions (see SF424 instructions in Part I, 4.4, items 6 and 7). CRISP and other databases cannot accept images.
World Molecular Imaging Congress
Sponsored by the Society for Molecular Imaging (SMI), the Academy of Molecular Imaging (AMI), the European Society for Molecular Imaging (ESMI) and the Federation of Asian Societies for Molecular Imaging (FASMI)
September 10-13, 2008, Nice, France
ISMRM Workshop on Frontiers of Magnetic Resonance: From Tumor Cell to Cancer Patient, September 13-16, 2008, Nice, France
ACRIN Fall Meeting, October 2-5, 2008, Ritz-Carleton Pentagon City, Arlington, VA
First International MR Focused Ultrasound Surgery Symposium, October 6-7, 2008, Washington, DC
Seventh International Conference on the Ultrasonic Measurement and Imaging of Tissue Elasticity, October 27-30, 2008, The Lakeway Resort and Spa, Lake Travis, Austin, TX
4th Annual Small Animal Imaging Workshop, November 5-8, 2008, Clark Auditorium, Stanford University
5th Annual Memphis BioImaging Conference
November 6-7, 2008, Fogelman Executive Conference Center, Memphis, TN
2008 RSNA Meeting, November 30 - December 5, 2008, McCormick Place, Chicago, Illinois
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program,
Division of Cancer Treatment and Diagnosis,
NCI 6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507